Note: this posting has been revised from the previous version. An analysis developed with the aid of the USAID-funded Deliver Project shows that Zambia is facing a massive gap in the financing required to reach country targets for expanded access to antiretroviral therapy (ART). The gap goes from $8.2 million for 2011 to a whopping […]
Here are some quick summaries of technological newsmakers from the past week: Two cancer drugs stop HIV in its tracks: Using a mixture of two anti-cancer drugs already on the market, researchers at the University of Minnesota say they have found a promising new treatment for HIV. During lab experiments with mice,” the drugs gemcitabine and […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]